Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts

This publication has 15 references indexed in Scilit:

• Broad-spectrum chemokine inhibition ameliorates experimental obliterative bronchiolitis
  The Annals of Thoracic Surgery, 2003
• Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents*
  Critical Care Medicine, 2002
• Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase
  Inflammation Research, 2001
• The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis
  Respiratory Research, 2001
• Resistance to endotoxic shock as a consequence of defective NF-kappa B activation in poly (ADP-ribose) polymerase-1 deficient mice
  The EMBO Journal, 1999
• Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase
  Cardiovascular Research, 1997
• LYMPHOCYTIC AIRWAY INFILTRATION AS A PRECURSOR TO FIBROUS OBLITERATION IN A RAT MODEL OF BRONCHIOLITIS OBLITERANS1,2
  Transplantation, 1997
• Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia–reperfusion injury in the heart and skeletal muscle
  Proceedings of the National Academy of Sciences, 1997
• Oxidant-induced Cytotoxicity: A Challenge for Metabolic Modulation
  American Journal of Respiratory Cell and Molecular Biology, 1991
• Immunohistochemical demonstration of poly(adenosine diphosphate-ribose) synthetase in bovine tissues.
  Journal of Histochemistry & Cytochemistry, 1983